Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

TSX:ATE - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > 2 Weeks away from Q3 update
View:
Post by Duster340 on Feb 01, 2023 9:49am

2 Weeks away from Q3 update

. will we get a start date for Phase ll
. will we get info on the IBD lead candidate
this board has gone silent, maybe it is the calm before the storm.
i think we will see some buying next week ahead of the financials report.
Comment by MrMugsy on Feb 01, 2023 4:50pm
The financials won't matter much unless it comes with an update.  Just looking for ~$42.5 MM as the yearend cash balance. I don't anticipate an IBD update until March. We are waiting on GMP pills in February and P1 in March. After March I anticipate two live streams of important work ... acute and chronic. Lots on the go but not much they're going to talk about right now.  ...more  
Comment by Doccole on Feb 01, 2023 4:52pm
The only consistency is inconsistency.   I've been hearing about the iBD for years. I've been hearing about "getting excited" "put us on the map" for years. can't wait for the next "pivot" I will be surprised if it even starts a phase II trial.  i hope I don't lose all my money, but I have 0 hope for this stock and company.  
Comment by MrMugsy on Feb 01, 2023 5:56pm
Just remember Doccole ... you don't have to believe anything. That's your right. That's how you end up picking winners and losers. You can do whatever you want - and - you can believe whatever you want. ---------------------------- Fact is ... drug development sucks in general. It's a tough game. If you know of a company that created a drug and got it to market quickly - stick ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities